Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling ParametersKevin H.M. Kuo, Susan P. Perrine, Gershwin T. Blyden et al.|Blood|2023Cited by 2